close

You are now leaving this site.

We do not review or control the content of external websites, and this hyperlink does not constitute an endorsement of the site’s content.

PROCEED STAY

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site, you consent to the use of these cookies.

RESOURCES AND SUPPORT

Gain access to personalized support

Kyowa Kirin Cares is a program that offers comprehensive support for people who have been prescribed POTELIGEO®. From help with navigating financial options to ongoing and personalized support throughout your journey with POTELIGEO, we are here every step of the way. Visit our support website to learn more about how Kyowa Kirin Cares can help you.

VISIT WEBSITE

To speak with a Kyowa Kirin Cares oncology nurse, call 833-KK-CARES (833-552-2737) Monday through Friday, 8 am to 8 pm (ET).

Tap in to important information about POTELIGEO® (mogamulizumab-kpkc) injection

Download the helpful resources below and review them with your healthcare provider.

Card image cap
DOCTOR DISCUSSION GUIDE

If you're considering POTELIGEO, use this guide to start the conversation with your healthcare provider.

DOWNLOAD
Card image cap
POTELIGEO BROCHURE

Looking for more information on POTELIGEO? This brochure is a useful resource.

DOWNLOAD

Connect with others

Though cutaneous T-cell lymphoma (CTCL) subtypes mycosis fungoides (MF) and Sézary syndrome (SS) are rare, you are not alone. Organizations exist to connect you with the information you may need, as well as opportunities to meet other people diagnosed with MF or SS. Learn more by visiting the following resources:

Get answers to your questions about POTELIGEO

Looking for more information on POTELIGEO? Review the frequently asked questions below or reach out to your healthcare provider.

POTELIGEO is used to treat MF or SS in adults who have tried at least one prior medicine (taken by mouth or injection) that did not work or in whom the disease has come back.

POTELIGEO is a monoclonal antibody that binds to certain cancerous T-cells, triggering your body’s immune cells to specifically target them.

POTELIGEO is administered through intravenous (IV) infusion by a trained healthcare provider at an infusion center. Each infusion will last at least 1 hour.

You will receive POTELIGEO once every week for the first 5 weeks and then once every other week ongoing.

Each person’s experience with POTELIGEO may be different. In the clinical trial, the longest time a person took POTELIGEO was 45.3 months.

You may notice improvements on your skin, but you should work closely with your healthcare provider to determine if and how POTELIGEO is working; there are a number of tests that can be done to assess response to treatment.

Each person’s experience with POTELIGEO may be different.

In the clinical trial, 42% of people taking POTELIGEO experienced response to treatment on their skin vs 16% of people taking the comparator treatment.

It is also important to know that drug rashes can occur with POTELIGEO. This is considered a side effect of treatment that can occur at any time while you're taking POTELIGEO. Let your healthcare provider know right away if you experience skin rash or any other side effects. Your healthcare provider will evaluate if it’s necessary to interrupt or stop treatment with POTELIGEO.

Each person’s experience with POTELIGEO may be different.

In the clinical trial, people taking POTELIGEO experienced greater control over their disease for more than twice as long as those taking the comparator treatment vorinostat (median of 7.6 months vs 3.1 months, respectively). The trial also showed that the percentage of people who experience partial or complete response to treatment was more than 5 times higher for the POTELIGEO group (28%) compared with the comparator group (5%). There was no evidence of disease (complete response) in 2% of people who took POTELIGEO, while no people taking vorinostat experienced complete response. Furthermore, in people who responded to treatment, those taking POTELIGEO experience response for longer than those taking the comparator treatment (median of 13.9 months vs 9.0 months, respectively).

The most common side effects of POTELIGEO include rash, tiredness, diarrhea, muscle and bone pain, and upper respiratory tract infection.

POTELIGEO may cause serious side effects including skin problems, infusion reactions, infections, autoimmune problems, and complications of stem cell transplant. Call your doctor if you develop symptoms or if symptoms get worse.

Let your healthcare provider know right away if you experience any symptoms such as chills or shaking, nausea, fever, rapid heartbeat, headache, and vomiting.

You are encouraged to report suspected adverse reactions to Kyowa Kirin, Inc. at 1-844-768-3544 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

A dedicated Kyowa Kirin Cares oncology nurse may help you figure out how much of the cost is covered by your insurance and/or if you apply for any financial assistance programs through Kyowa Kirin Cares.

Thanks for signing up!

You’re signed up to receive the latest information on your disease and POTELIGEO. Check your inbox for a confirmation email.

Sign up to stay connected

(US residents only)

Sign up to receive information and resources about your disease and POTELIGEO. Simply fill out the form below.

* Required

This field is required
This field is required
This field is required

I AM A

TAKING POTELIGEO?

By clicking “Sign up” and providing your name, email address, or other personal information, you agree that Kyowa Kirin and others working on behalf of Kyowa Kirin may send you POTELIGEO.com content updates and educational materials about MF/SS and POTELIGEO, use the information that you have submitted to develop or improve products and services, and contact you in the future about educational programs, health-related topics, and advancements in the treatment of MF/SS. Kyowa Kirin respects the privacy of visitors to its websites, and we recognize your need for protection and management of personally identifiable information you share with us (any information by which you can be identified, including, but not limited to, name, address, email address, and telephone number). Click here to read the Kyowa Kirin Privacy Policy.

INDICATION AND IMPORTANT SAFETY INFORMATION

What is POTELIGEO® (mogamulizumab-kpkc)?

POTELIGEO is a prescription medicine used to treat mycosis fungoides (MF) or Sézary syndrome (SS) in adults who have tried at least one prior medicine (taken by mouth or injection) that did not work or in whom the disease has come back.

Important Safety Information

What is the most important information I should know about POTELIGEO?

POTELIGEO may cause serious side effects that can be severe or life-threatening including skin problems, infusion reactions, infections, autoimmune problems, and complications from stem cell transplant.

Call or see your healthcare provider right away if you develop any symptoms of the following problems or if these symptoms get worse:

  • Skin problems: Signs and symptoms of skin reactions may include skin pain, itching, skin blistering or peeling, rash, painful sores or ulcers in your mouth, nose, throat or genital area.
  • Infusion reactions: Signs and symptoms of infusion reactions may include chills or shaking, redness on your face (flushing), itching or rash, shortness of breath, coughing or wheezing, dizziness, feeling like passing out, tiredness, fever.
  • Infections: Signs and symptoms of infection may include fever, sweats or chills, nausea, flu-like symptoms, sore throat or difficulty swallowing, shortness of breath, diarrhea or stomach pain, cough.
  • Autoimmune problems: Some people receiving POTELIGEO may develop autoimmune problems, and some people who already have an autoimmune disease may get worse during treatment with POTELIGEO.
  • Complications of stem cell transplant: Patients who receive a stem cell transplant using donor stem cells (allogeneic) after treatment with POTELIGEO may experience complications that can be severe and lead to death. Your healthcare provider will monitor you for signs of complications if you have an allogeneic stem cell transplant.

What are the most common side effects of POTELIGEO?

The most common side effects of POTELIGEO include rash, tiredness, diarrhea, muscle and bone pain, and upper respiratory tract infection.

Before starting POTELIGEO treatment, tell your doctor about all your medical conditions, including whether you:

  • have had a severe skin reaction after receiving POTELIGEO
  • have had an infusion reaction during or after receiving POTELIGEO
  • have or have had liver problems including hepatitis B (HBV) infection
  • have a history of autoimmune problems
  • have undergone or plan to have a stem cell transplant, using cells from a donor
  • have lung or breathing problems
  • are pregnant or plan to become pregnant
    • It is not known if POTELIGEO will harm your unborn baby
  • are breastfeeding or plan to breastfeed
    • Talk to your healthcare provider about the best way to feed your baby during treatment with POTELIGEO

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

You are encouraged to report suspected adverse reactions to Kyowa Kirin, Inc. at 1-844-768-3544 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

pdf iconPLEASE SEE PATIENT INFORMATION.

What is POTELIGEO® (mogamulizumab-kpkc)?

POTELIGEO is a prescription medicine used to treat mycosis fungoides (MF) or Sézary syndrome (SS) in adults who have tried at least one prior medicine (taken by mouth or injection) that did not work or in whom the disease has come back.

Important Safety Information

What is the most important information I should know about POTELIGEO?

POTELIGEO may cause serious side effects that can be severe or life-threatening including skin problems, infusion reactions, infections, autoimmune problems, and complications from stem cell transplant.

Call or see your healthcare provider right away if you develop any symptoms of the following problems or if these symptoms get worse:

  • Skin problems: Signs and symptoms of skin reactions may include skin pain, itching, skin blistering or peeling, rash, painful sores or ulcers in your mouth, nose, throat or genital area.
  • Infusion reactions: Signs and symptoms of infusion reactions may include chills or shaking, redness on your face (flushing), itching or rash, shortness of breath, coughing or wheezing, dizziness, feeling like passing out, tiredness, fever.
  • Infections: Signs and symptoms of infection may include fever, sweats or chills, nausea, flu-like symptoms, sore throat or difficulty swallowing, shortness of breath, diarrhea or stomach pain, cough.
  • Autoimmune problems: Some people receiving POTELIGEO may develop autoimmune problems, and some people who already have an autoimmune disease may get worse during treatment with POTELIGEO.
  • Complications of stem cell transplant: Patients who receive a stem cell transplant using donor stem cells (allogeneic) after treatment with POTELIGEO may experience complications that can be severe and lead to death. Your healthcare provider will monitor you for signs of complications if you have an allogeneic stem cell transplant.

What are the most common side effects of POTELIGEO?

The most common side effects of POTELIGEO include rash, tiredness, diarrhea, muscle and bone pain, and upper respiratory tract infection.

Before starting POTELIGEO treatment, tell your doctor about all your medical conditions, including whether you:

  • have had a severe skin reaction after receiving POTELIGEO
  • have had an infusion reaction during or after receiving POTELIGEO
  • have or have had liver problems including hepatitis B (HBV) infection
  • have a history of autoimmune problems
  • have undergone or plan to have a stem cell transplant, using cells from a donor
  • have lung or breathing problems
  • are pregnant or plan to become pregnant
    • It is not known if POTELIGEO will harm your unborn baby
  • are breastfeeding or plan to breastfeed
    • Talk to your healthcare provider about the best way to feed your baby during treatment with POTELIGEO

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

You are encouraged to report suspected adverse reactions to Kyowa Kirin, Inc. at 1-844-768-3544 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

pdf iconPLEASE SEE PATIENT INFORMATION.
close

Sign up to stay connected

Receive the latest information on mycosis fungoides, Sézary syndrome, and POTELIGEO.

STAY CONNECTED